Literature DB >> 17763326

Comparison of CD8+ T Cell responses to cytomegalovirus between human fetuses and their transmitter mothers.

Beatrice Pedron1, Valerie Guerin, Francois Jacquemard, Aline Munier, Fernand Daffos, Philippe Thulliez, Yannick Aujard, Dominique Luton, Ghislaine Sterkers.   

Abstract

BACKGROUND: The mechanisms responsible for the increased susceptibility of fetuses to cytomegalovirus (CMV) were studied by comparing CD8(+) T cell responses to the virus in susceptible fetuses to those in their comparatively more resistant mothers.
METHODS: Included in the study were 16 transmitter mothers who underwent seroconversion during the first trimester of pregnancy as well as their fetuses, who were positive for CMV in amniotic fluid by polymerase chain reaction at 17-19 weeks of gestation. Fetal and maternal blood samples were collected between the 22nd and 39th week of gestation. Cytotoxic T lymphocytes (CTLs) that had activated (HLA-DR(+)), effector/memory (CD28(-)), and memory (CD18(high)) phenotypes; that stained with the HLA-A2/pp65 or the HLA-B7/pp65 multimer; and that secreted interferon (IFN)- gamma were enumerated by flow cytometry. Viral loads were determined simultaneously.
RESULTS: The results showed (1) similar levels of activated, effector/memory, and memory CTLs in fetuses and mothers but a smaller pp65-specific CTL pool in fetuses (median, 0.015% vs. 0.99%; P=.003); (2) similar percentages of CTLs secreting IFN- gamma after stimulation with ionomycin/phorbol myristate acetate in fetuses and mothers but lower percentages of CTLs secreting IFN- gamma after stimulation with a CD3 monoclonal antibody in fetuses (median, 1% vs. 14%; P=.01); and (3) higher viral loads (mean, 17,290 vs. <250 genome equivalents/mL) in fetuses.
CONCLUSION: Impaired viral clearance might be related to a defective expansion of the pp65-specific CTL pool and/or to the immaturity of IFN- gamma -secreting cells in fetuses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763326     DOI: 10.1086/521196

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Immune responses to congenital cytomegalovirus infection.

Authors:  Ilija Brizić; Lea Hiršl; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

Review 2.  Dissecting the defects in the neonatal CD8+ T-cell response.

Authors:  Adam J Fike; Ogan K Kumova; Alison J Carey
Journal:  J Leukoc Biol       Date:  2019-07-01       Impact factor: 4.962

3.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

4.  Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission.

Authors:  Erica L Johnson; Chanie L Howard; Joy Thurman; Kyle Pontiff; Elan S Johnson; Rana Chakraborty
Journal:  J Infect Dis       Date:  2014-07-31       Impact factor: 5.226

Review 5.  Cytomegalovirus in the neonate: immune correlates of infection and protection.

Authors:  Mark R Schleiss
Journal:  Clin Dev Immunol       Date:  2013-08-19

Review 6.  Immunity to cytomegalovirus in early life.

Authors:  Ariane Huygens; Nicolas Dauby; David Vermijlen; Arnaud Marchant
Journal:  Front Immunol       Date:  2014-10-30       Impact factor: 7.561

7.  Cytomegalovirus-Specific T Cell Epitope Recognition in Congenital Cytomegalovirus Mother-Infant Pairs.

Authors:  Emma C Materne; Daniele Lilleri; Francesca Garofoli; Giuseppina Lombardi; Milena Furione; Maurizio Zavattoni; Laura Gibson
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

Review 8.  The impact of differential antiviral immunity in children and adults.

Authors:  Andrew J Prendergast; Paul Klenerman; Philip J R Goulder
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

Review 9.  The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.

Authors:  Francesco Saglio; Patrick J Hanley; Catherine M Bollard
Journal:  Cytotherapy       Date:  2014-02       Impact factor: 5.414

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.